Daniel Clemente

1.5k total citations
39 papers, 374 citations indexed

About

Daniel Clemente is a scholar working on Hematology, Surgery and Rheumatology. According to data from OpenAlex, Daniel Clemente has authored 39 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 12 papers in Surgery and 12 papers in Rheumatology. Recurrent topics in Daniel Clemente's work include Autoimmune and Inflammatory Disorders Research (17 papers), Adolescent and Pediatric Healthcare (7 papers) and Inflammasome and immune disorders (7 papers). Daniel Clemente is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (17 papers), Adolescent and Pediatric Healthcare (7 papers) and Inflammasome and immune disorders (7 papers). Daniel Clemente collaborates with scholars based in Spain, United States and Italy. Daniel Clemente's co-authors include Leticia León, Kirsten Minden, Helen Foster, Loreto Carmona, Cristina Calvo, Esmeralda Núñez Cuadros, Elisa Fernández-Cooke, Lydia Abásolo, Jesús Saavedra‐Lozano and Rosa Alcobendas and has published in prestigious journals such as PLoS ONE, Annals of the Rheumatic Diseases and Intensive Care Medicine.

In The Last Decade

Daniel Clemente

32 papers receiving 368 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Clemente Spain 10 162 89 74 73 72 39 374
Andreas Woerner Switzerland 11 90 0.6× 85 1.0× 208 2.8× 54 0.7× 41 0.6× 27 377
Roberta Berard Canada 12 79 0.5× 122 1.4× 210 2.8× 82 1.1× 75 1.0× 40 418
Janice B. Heikenen United States 11 398 2.5× 79 0.9× 76 1.0× 61 0.8× 38 0.5× 17 886
Alfonso Martínez United States 5 202 1.2× 75 0.8× 44 0.6× 69 0.9× 39 0.5× 10 612
JT Boyle United States 3 271 1.7× 143 1.6× 97 1.3× 120 1.6× 22 0.3× 4 832
Jorge M. Lopez‐Benitez United States 11 34 0.2× 85 1.0× 204 2.8× 41 0.6× 93 1.3× 13 472
Tova Ronis United States 8 56 0.3× 80 0.9× 80 1.1× 55 0.8× 42 0.6× 18 263
Fatih Haşlak Türkiye 12 118 0.7× 21 0.2× 109 1.5× 16 0.2× 55 0.8× 59 425
Grand Rj United States 3 286 1.8× 143 1.6× 98 1.3× 119 1.6× 23 0.3× 3 849
Jennifer B. Soep United States 10 81 0.5× 64 0.7× 154 2.1× 8 0.1× 92 1.3× 19 435

Countries citing papers authored by Daniel Clemente

Since Specialization
Citations

This map shows the geographic impact of Daniel Clemente's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Clemente with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Clemente more than expected).

Fields of papers citing papers by Daniel Clemente

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Clemente. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Clemente. The network helps show where Daniel Clemente may publish in the future.

Co-authorship network of co-authors of Daniel Clemente

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Clemente. A scholar is included among the top collaborators of Daniel Clemente based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Clemente. Daniel Clemente is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Clemente, Daniel, Leticia León, Juan Carlos Nieto‐González, et al.. (2025). Incidence and reasons for biologic and targeted synthetic DMARD switching in juvenile idiopathic arthritis: a real- life stratified analysis. Pediatric Rheumatology. 23(1). 42–42. 2 indexed citations
2.
Benedetti, Fabrizio De, Ivan Foeldvari, Nadina Rubio‐Pérez, et al.. (2025). Sarilumab in Polyarticular‐Course Juvenile Idiopathic Arthritis: Dose‐Finding and 1‐Year Analysis of a Phase 2b, Open‐Label, Multicenter Study. Arthritis Care & Research.
3.
Clemente, Daniel, et al.. (2024). STING‐associated vasculopathy with onset in infancy (SAVI) presenting with skin lesions. Pediatric Dermatology. 41(5). 893–896.
4.
León, Leticia, et al.. (2024). Self-esteem, self-concept, and body image of young people with rheumatic and musculoskeletal diseases: A systematic literature review. Seminars in Arthritis and Rheumatism. 68. 152486–152486. 6 indexed citations
5.
Nieto‐González, Juan Carlos, et al.. (2023). What to Expect When Systemic Treatment in Juvenile Idiopathic Arthritis Is Withdrawn?. The Journal of Rheumatology. 50(10). 1326–1332. 1 indexed citations
8.
Strangfeld, Anja, Laure Gossec, Loreto Carmona, et al.. (2022). POS1212 SARS-CoV-2 VACCINE SAFETY IN ADOLESCENTS WITH INFLAMMATORY RHEUMATIC AND MUSCULOSKELETAL DISEASES AND ADULTS WITH JUVENILE IDIOPATHIC ARTHRITIS. Annals of the Rheumatic Diseases. 81. 934–935.
10.
11.
Corradi, Guido, et al.. (2022). Negative experiences with public bathrooms and chronic illness‐related shame. Neurourology and Urodynamics. 42(2). 539–546. 2 indexed citations
12.
Clemente, Daniel, Jaime de Inocencio Arocena, Juan Carlos Nieto‐González, et al.. (2021). Clinical characteristics and COVID-19 outcomes in a regional cohort of pediatric patients with rheumatic diseases. Pediatric Rheumatology. 19(1). 162–162. 12 indexed citations
13.
Fernández-Cooke, Elisa, Judith Sánchez-Manubens, Jordi Antón, et al.. (2019). Epidemiological and clinical features of Kawasaki disease in Spain over 5 years and risk factors for aneurysm development. (2011-2016): KAWA-RACE study group. PLoS ONE. 14(5). e0215665–e0215665. 41 indexed citations
14.
García‐Salido, Alberto, Daniel Clemente, Silvia Escalada Pellitero, & Ana Serrano‐González. (2019). A thirty second pause. Intensive Care Medicine. 45(5). 707–708. 3 indexed citations
15.
Clemente, Daniel, et al.. (2018). Artritis séptica como forma de inicio de una piomiositis. Reumatología Clínica. 16(3). 247–248.
16.
Clemente, Daniel, Leticia León, Helen Foster, Loreto Carmona, & Kirsten Minden. (2017). Transitional care for rheumatic conditions in Europe: current clinical practice and available resources. Pediatric Rheumatology. 15(1). 49–49. 36 indexed citations
17.
Clemente, Daniel, Leticia León, Helen Foster, Kirsten Minden, & Loreto Carmona. (2016). Systematic review and critical appraisal of transitional care programmes in rheumatology. Seminars in Arthritis and Rheumatism. 46(3). 372–379. 54 indexed citations
18.
Mauro, Michele Di, Angela L. Iacò, Daniel Clemente, et al.. (2014). Left ventricular surgical remodelling: is it a matter of shape or volume?. European Journal of Cardio-Thoracic Surgery. 47(3). 473–479. 13 indexed citations
19.
Loza, Estíbaliz, Lydia Abásolo, Daniel Clemente, et al.. (2007). Variability in the use of orthopedic surgery in patients with rheumatoid arthritis in Spain.. PubMed. 34(7). 1485–90. 21 indexed citations
20.
Clemente, Daniel, César Hernández‐García, Lydia Abásolo, et al.. (2007). Disminución del tiempo hasta el primer tratamiento con fármacos modificadores de la enfermedad en pacientes con artritis reumatoide. Reumatología Clínica. 3(6). 245–250. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026